NCT06310967View on ClinicalTrials.gov

A Dose Escalation Study of IG3018 in Subjects With Hyperuricemia With or Without Chronic Kidney Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 12, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
HyperuricemiaHypouricemia, Renal
Interventions
DRUG

IG3018

Oral administration

OTHER

Placebo matching IG3018

Oral administration

Trial Locations (3)

2019

RECRUITING

Emeritus Research Pty Ltd -Sydney, Botany

2289

RECRUITING

Pendlebury Research Pty Ltd T/A Novatrials, Kotara

3124

RECRUITING

Emeritus Research Pty Ltd -Melbourne, Camberwell

All Listed Sponsors
lead

Intelligem Therapeutics Australia Pty Ltd.

INDUSTRY